Objectives Australian guidelines recommend 50-70 years consider taking aspirin to reduce their bowel cancer risk.We trialled a decision aid in general practice to facilitate the implementation of these guidelines into...Objectives Australian guidelines recommend 50-70 years consider taking aspirin to reduce their bowel cancer risk.We trialled a decision aid in general practice to facilitate the implementation of these guidelines into clinical practice.This publication reports on the qualitative results from the process evaluation of the trial.We aimed to explore general practitioners’(GPs)and their patients’approach to shared decision-making(SDM)about taking aspirin to prevent bowel cancer and how the decision aids were used in practice.Methods Semistructured interviews were conducted with 17 participants who received the decision aid and 12 GPs who participated in the trial between June and November 2021.The interviews were coded inductively,and emerging themes were mapped onto the Revised Programme Theory for SDM.Results The study highlighted the dynamics of SDM for taking aspirin to prevent bowel cancer.Some participants discussed the decision aid with their GPs as advised prior to taking aspirin,others either took aspirin or dismissed it outright without discussing it with their GPs.Notably,participants’trust in their GPs,and participants’diverse worldviews played pivotal roles in their decisions.Although the decision aid supported SDM for some,it was not always prioritised in a consultation.This was likely impacted during the trial period as the COVID-19 pandemic was the focus for general practice.Conclusion In summary,this study illustrated the complexities of SDM through using a decision aid in general practice to implement the guidelines for low-dose aspirin to prevent bowel cancer.While the decision aid prompted some participants to speak to their GPs,they were also heavily influenced by their unwavering trust in the GPs and their different worldviews.In the face of the COVID-19 pandemic,SDM was not highly prioritised.This study provides insights into the implementation of guidelines into clinical practice and highlights the need for ongoing support and prioritisation of cancer prevention in general practice consultations.展开更多
基金funded by a dedicated grant from the Victorian Cancer Agency Cancer Prevention and Screening Research Grant CPSRG19011supported by an NHMRC Investigator grant APP1195302 and is an Associate Director of the CanTest Collaborative(funded by Cancer Research UK C8640/A23385)upported by an ARC Laureate Fellowship FL190100035.
文摘Objectives Australian guidelines recommend 50-70 years consider taking aspirin to reduce their bowel cancer risk.We trialled a decision aid in general practice to facilitate the implementation of these guidelines into clinical practice.This publication reports on the qualitative results from the process evaluation of the trial.We aimed to explore general practitioners’(GPs)and their patients’approach to shared decision-making(SDM)about taking aspirin to prevent bowel cancer and how the decision aids were used in practice.Methods Semistructured interviews were conducted with 17 participants who received the decision aid and 12 GPs who participated in the trial between June and November 2021.The interviews were coded inductively,and emerging themes were mapped onto the Revised Programme Theory for SDM.Results The study highlighted the dynamics of SDM for taking aspirin to prevent bowel cancer.Some participants discussed the decision aid with their GPs as advised prior to taking aspirin,others either took aspirin or dismissed it outright without discussing it with their GPs.Notably,participants’trust in their GPs,and participants’diverse worldviews played pivotal roles in their decisions.Although the decision aid supported SDM for some,it was not always prioritised in a consultation.This was likely impacted during the trial period as the COVID-19 pandemic was the focus for general practice.Conclusion In summary,this study illustrated the complexities of SDM through using a decision aid in general practice to implement the guidelines for low-dose aspirin to prevent bowel cancer.While the decision aid prompted some participants to speak to their GPs,they were also heavily influenced by their unwavering trust in the GPs and their different worldviews.In the face of the COVID-19 pandemic,SDM was not highly prioritised.This study provides insights into the implementation of guidelines into clinical practice and highlights the need for ongoing support and prioritisation of cancer prevention in general practice consultations.
